glp 1 and weight lifting GLP-1 Strength Training: Avoid Muscle Loss Taking GLP-1s for weight loss?

Effects of biliopancreatic diversion on diurnal leptin, insulin and free fatty acid levels

Semaglutide is a GLP-1 analogue with an Aib (2-amino isobutyric acid) in position 2 and a C18 chain linked to K20 through a small PEG spacer which was accepted by the FDA in 2018 for the treatment of diabetes as a once weekly treatment and is presently in phase 3 clinical trial for a once daily oral treatment 50,51

Kidney issues: While weight loss injections themselves do not directly impair kidney function, some people may develop it as a secondary consequence, primarily due to severe or prolonged dehydration caused by gastrointestinal side effects

Key numbers: +0.04 mmol/L in fasting glucose +0.060.08% in HbA1c +10% increase in diabetes risk with low/moderate-intensity statins +36% with high-intensity statins The effect is most evident in patients already at risk, with glucose values near the diagnostic threshold